ESDS Software shares extended their post-listing rally for a third session, rising 16.21% to Rs 1,266, nearly 195% above the IPO price of Rs 429. The surge follows a 136-times subscribed IPO, improved financial performance and plans to invest heavily in cloud and data-centre infrastructure.
Biocon shares rise 2% on 10-year Pertuzumab supply deal for breast cancer therapy in Brazil
Biocon shares rose after the company secured a 10-year Pertuzumab supply contract in Brazil. The consortium with Bahiafarma and Bionovis received full allocation under the